Anti-inflammatory Effects of Perioperative Dexmedetomidine Administered as an Adjunct to General Anesthesia: A Meta-analysis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Bo ^a   Li, Yalan ^b   Tian, Shushi ^c   Wang, Huixia ^a   Wu, Hui ^d   Zhang, Aihua ^e   Gao, Chengjie ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b JINAN UNIVERSITY   (China)

^c No 261 Hospital of PLA   (China)

^d People s Hospital of Zhangqiu   (China)

^e Yancheng City No1 People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; DEXMEDETOMIDINE; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; AGED; BLOOD; CHILD; GENERAL ANESTHESIA; HUMAN; INFANT; INFLAMMATION; META ANALYSIS; MIDDLE AGED; PERIOPERATIVE PERIOD; PRESCHOOL CHILD; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANESTHESIA, GENERAL; ANTI-INFLAMMATORY AGENTS; BIOMARKERS; CHILD; CHILD, PRESCHOOL; DEXMEDETOMIDINE; HUMANS; INFANT; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; MIDDLE AGED; PERIOPERATIVE CARE; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84937681570     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep12342     Document Type: Article

References (49)

1. Gouin, J. P. & Kiecolt-Glaser, J. K. The impact of psychological stress on wound healing: methods and mechanisms. Immunol Allergy Clin North Am. 31, 81-93 (2011).
2. Eming, S. A., Krieg, T. & Davidson, J. M. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 127, 514-25 (2007).
3. Venn, R. M., Karol, M. D. & Grounds, R. M. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth. 88, 669-75 (2002).
4. Bekker, A. et al. The effect of dexmedetomidine on perioperative hemodynamics in patients undergoing craniotomy. Anesth Analg. 107, 1340-7 (2008).
5. Piao, G. & Wu, J. Systematic assessment of dexmedetomidine as an anesthetic agent: a meta-analysis of randomized controlled trials. Arch Med Sci. 10, 19-24 (2014).
6. Biccard, B. M., Goga, S. & de Beurs, J. Dexmedetomidine and cardiac protection for non-cardiac surgery: a meta-analysis of randomised controlled trials. Anaesth. 63, 4-14 (2008).
7. Ji, F. et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 127, 1576-84 (2013).
8. Ji, F., Li, Z., Young, J. N., Yeranossian, A. & Liu, H. Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One. 8, e77446 (2013).
9. Ji, F., Li, Z., Young, N., Moore, P. & Liu, H. Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 28, 267-73 (2014).
10. Taniguchi, T., Kidani, Y., Kanakura, H., Takemoto, Y. & Yamamoto, K. Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Critical Care Med. 32, 1322-6 (2004).
11. Yagmurdur, H. et al. Dexmedetomidine reduces the ischemia-reperfusion injury markers during upper extremity surgery with tourniquet. J Hand Surgery. 33, 941-7 (2008).
12. Sukegawa, S. et al. Locally injected dexmedetomidine inhibits carrageenin-induced inflammatory responses in the injected region. Anesth Analg. 118, 473-80 (2014).
13. Kawasaki, T. et al. Dexmedetomidine suppresses proinflammatory mediator production in human whole blood in vitro. J Trauma Acute Care Surg. 74, 1370-5 (2013).
14. Bekker, A. et al. The effect of intraoperative infusion of dexmedetomidine on the quality of recovery after major spinal surgery. J Neurosurg Anesthesiol. 25, 16-24 (2013).
15. Kang, S. H. et al. Effects of dexmedetomidine on inflammatory responses in patients undergoing laparoscopic cholecystectomy. Acta Anaesthesiol Scand. 57, 480-7 (2013).
16. Kim, Y. et al. Effects of dexmedetomidine on the ratio of T helper 1 to T helper 2 cytokines in patients undergoing laparoscopic cholecystectomy. J Clin Anesth. 26, 281-5 (2014).
17. Liu, H. L. & Qian, Y. N. Effects of dexmedetomidine on perioperative inflammatory response in patients undergoing valve replacement. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 29, 316-7 (2013).
18. Naguib, A. N. et al. The role of different anesthetic techniques in altering the stress response during cardiac surgery in children: a prospective, double-blinded, and randomized study. Pediatr Crit Care Med. 14, 481-90 (2013).
19. Tasdogan, M., Memis, D., Sut, N. & Yuksel, M. Results of a pilot study on the effects of propofol and dexmedetomidine on inflammatory responses and intraabdominal pressure in severe sepsis. J Clin Anesth. 21, 394-400 (2009).
20. Ueki, M. et al. The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass. Anaesthesia. 69, 693-700 (2014).
21. Venn, R. M. et al. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth. 86, 650-656 (2001).
22. Wang, Z. X. et al. Dexmedetomidine reduces intestinal and hepatic injury after hepatectomy with inflow occlusion under general anaesthesia: a randomized controlled trial. Br J Anaesth. 112, 1055-64 (2014).
23. Yacout, A. G., Osman, H. A., Abdel-Daem, M. H., Hammouda, S. A. & Elsawy, M. M. Effect of intravenous dexmedetomidine infusion on some proinflammatory cytokines, stress hormones and recovery profile in major abdominal surgery. Alexandria J Med. 48, 3-8 (2012).
24. Zhang, J. & Zhang, W. Effects of dexmedetomidine on inflammatory responses in patients undergoing cardiac valve replacement with cardiopulmonary bypass. Chin J Anesthesiol. 33, 1188-91 (2013).
25. Zhang, L. et al. Effect of dexmedetomidine on inflammatory cytokines of patients undergoing cerebral surgery during perioperative period. Chin J Nosocomiol. 22, 2752-54 (2012).
26. Zhang, W., Zhang, J. & Meng, F. Effect of dexmedetomidine combined with continuous positive airway pressure on oxidative stress and inflammatory responses during one-lung ventilation in elderly patients undergoing radical surgery for esophageal carcinoma. Chin J Anesthesiol. 34, 5-8 (2014).
27. Zhong, Z., He, D., Zhang, L., Min, S. & Shen, J. Effect of sedation by infusion of dexmedetomidine on inflammatory factors in patients with severe trauma. Chin J Pathophysiol. 28, 1981-8 (2012).
28. Zhu, H. Effects of dexmedetomidine on intrapulmonary shunt and inflammatory response in patients. Chin J Postgrad Med. 35, 29-32 (2012).
29. Higgins, J. P. et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 343, d5928 (2011).
30. Higgins, J. P. & Green, S. editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. London: Cochrane Collaboration (2009).
31. Hozo, S. P. et al. Estimating mean and variance from median, range and the size of a sample. BMC Res Methodol. 5, 13 (2005).
32. McBride, W. T., Armstrong, M. A. & McBride, S. J. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia. 51, 465-73 (1996).
33. Cohen, D., Horiuchi, K., Kemper, M. & Weisman, C. Modulating effects of propofol on metabolic and cardiopulmonary responses to stressful intensive care unit procedures. Crit Care Med. 24, 612-7 (1996).
34. Sheeran, P. & Hall, G. M. Cytokines in anesthesia. BJA. 78, 201-19 (1997).
35. Jameson, P., Desborough, J. P., Bryant, A. E. & Hall, G. M. The effect of cortisol suppression on IL-6 and white blood cell responses to surgery. Acta Anaesthiol Scand. 41, 304-8 (1997).
36. Clark, I. A. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 18, 335-43 (2007).
37. Olmos, G. & Llado, J. Tumor necrosis factor alpha: A link between neuroinflammation and excitotoxicity. Mediators Inflamm. 2014, 861231 (2014).
38. Lotti, F. & Maggi, M. Interleukin 8 and the male genital tract. J Reprod Immunol. 100, 54-65 (2013).
39. Todorovic-Rakovic, N. & Milovanovic, J. Interleukin-8 in breast cancer progression. J Interferon Cytokine Res. 33, 563-70 (2013).
40. McAfoose, J. & Baune, B. T. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev. 33, 355-66 (2009).
41. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. NatRev Neurosci. 9, 46-56 (2008).
42. Koca, U. et al. The effects of dexmedetomidine on secondary acute lung and kidney injuries in the rat model of intra-abdominal sepsis. Sci World J. 2013, 292687 (2013).
43. Tan, J. A. & Ho, K. M. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med. 36, 926-39 (2010).
44. Xia, Z. Q. et al. Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta-analysis of randomized clinical trials. J Surg Res. 185, 833-43 (2013).
45. Pasin, L. et al. Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials. PLoS One. 8, e82913 (2013).
46. Hofer, S. et al., Central sympatholytics prolong survival in experimental sepsis. Crit Care. 13, R11 (2009).
47. Kurosawa, S. & Kato, M. Anesthetics, immune cells, and immune responses. J Anesth. 22, 263-77 (2008).
48. Najera-Medina, O. et al. Cytokine patterns in paediatric patients presenting serious gastrointestinal and respiratory bacterial infections. Centr Eur J Immunol. 39, 223-227 (2014).
49. Kaack, M. B., Harrison, R. M. & Roberts, J. A. Effect of age and hormonal state on cytokine synthesis in the monkey. Cytokine. 10, 236-239 (1998).